Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025
Cara Therapeutics Employees
Cara Therapeutics had 10 employees as of December 31, 2024. The number of employees decreased by 45 or -81.82% compared to the previous year.
Employees
10
Change (1Y)
-45
Growth (1Y)
-81.82%
Revenue / Employee
$713,700
Profits / Employee
-$7,086,700
Market Cap
24.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | -45 | -81.82% |
| Dec 31, 2023 | 55 | -51 | -48.11% |
| Dec 31, 2022 | 106 | 22 | 26.19% |
| Dec 31, 2021 | 84 | 4 | 5.00% |
| Dec 31, 2020 | 80 | 13 | 19.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CARA News
- 5 months ago - Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics - GlobeNewsWire
- 5 months ago - Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics - GlobeNewsWire
- 7 months ago - CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc. - CARA - Business Wire
- 9 months ago - Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - GlobeNewsWire
- 9 months ago - Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement - GlobeNewsWire
- 1 year ago - These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers' - Benzinga
- 1 year ago - Cara Therapeutics discontinues study on a neurological condition as drug fails - Reuters
- 1 year ago - Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica - GlobeNewsWire